ArticleJournal of the National Cancer Institute2019

TP53 Status as a Determinant of Pro- vs Anti-Tumorigenic Effects of Estrogen Receptor-Beta in Breast Cancer.

Utpal K Mukhopadhyay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.